AKT1 and nonpapillary renal cell carcinoma: These findings further confirm that CVB blocks the progression of ccRCC by modulating proliferation, EMT, angiogenesis and apoptosis through the inhibition of the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway.